Ignyta, Inc. is a personalized medicine company developing revolutionary new products and services to customize diagnosis and treatment of patients with rheumatoid arthritis, lupus and other autoimmune diseases.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 01/02/13 | $5,500,000 | Series B |
City Hill Ventures Colt Ventures | undisclosed |
